Raleigh Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Raleigh Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Raleigh Capital Management from 13F filings

Historical chart of Raleigh Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Raleigh Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Raleigh Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $89k 212 418.00
2023-12-31 $20k 50 406.89
2023-09-30 $7.0k 20 350.40
2023-06-30 $6.7k 19 351.89
2023-03-31 $6.0k 19 315.05
2021-12-31 $1.0k 4 250.00

More positions owned by Raleigh Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ssga Active Tr Spdr Ssga Fxd (FISR)
Ssga Active Tr Spdr Ssga Us Sct (XLSR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Verizon Communications (VZ)
Philip Morris International (PM)
Duke Energy Corp Com New (DUK)
Southern Company (SO)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Bloomberg High Y (JNK)

View all positions for Raleigh Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated